USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
Canada: Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland and Labrador; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon
Grants of up to $60,000 to USA and Canada nonprofit institutions, organizations, and researchers for cancer research projects. Funding is intended to support early-career scientists focused on a medical area that has historically received limited researcher attention. Specifically, funding may be used to research strategies that may lead to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FPD.
A research and advocacy venture committed to funding world-class, innovative, and cross-disciplinary cancer research to develop a cancer prevention therapy for RUNX1 familial platelet disorder (RUNX1-FPD) with predisposition to blood cancer. The program also aims to support, inform, educate, and connect patients, healthcare providers, researchers, and other stakeholders in the RUNX1 community.
Aims of research proposals must be relevant to the goal of preventing hematologic malignant transformation in RUNX1-FPD. Proposals that seek to translate from bench to bedside will receive priority.
Example areas of research interests include:
Estimated Size of Grant:
The RUNX1 Early Career Investigator grant is a 3-year award.
- Project Start Date: April 2023 (contingent upon receipt and approval of new award requirements)
- Project End Date: April 2026
Apply online: https://alsfapps.force.com/FGM_Portal__CommunitySignin
If you have any questions regarding your eligibility or your research proposal topic, the Foundation encourages you to reach out to Katrin Ericson, Executive Director at RRP at kericson@runx1-fpd.org.
All other questions can be submitted to Margaret Poore at M.Poore@AlexsLemonade.org.
Alex’s Lemonade Stand Foundation for Childhood Cancer
333 E. Lancaster Ave, #414
Wynnewood, PA 19096 USA
Phone: 866.333.1213